Soltis Investment Advisors LLC

Position in EXEL — Exelixis, Inc.

CIK 1802530 ST. GEORGE, UT

Position in EXEL

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$247,456

New position

Shares Held

4,548

first reported quarter

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#556

of 757 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 42% Shared 0% None 58%

Healthcare · as of Jun 30, 2026

Soltis Investment Advisors LLC holds $1,389,119 across 4 Biotechnology names. EXEL ranks #3 (17.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,094	$543,422
2	REGN	Regeneron Pharmaceuticals, Inc.	810	$505,067
3	EXEL	Exelixis, Inc. This page	4,548	$247,456
4	LXEO	Lexeo Therapeutics, Inc.	20,016	$93,174

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$247,456	4,548	—	Shares	Sole	2026-07-31
No filing history on record for this holder in this stock.